← All funded startups

August 7, 2026

Mironid

Mironid is a Glasgow-based biopharmaceutical company developing drug candidates for degenerative and rare genetic kidney diseases.

Round: Series B
Amount raised: $46M
Lead investor: Scottish National Investment Bank
Industry: Biotechnology, Pharmaceuticals
Headquarters: Glasgow, United Kingdom
Employees: —
Website: mironid.com
LinkedIn: —

Other investors

Roche Venture Fund
Epidarex Capital
Sofinnova Partners
BioGeneration Ventures
University of Strathclyde

Source: EU-Startups